HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.

AbstractBACKGROUND:
Hydroxyethylstarch used for volume restoration in brain-dead kidney donors has been associated with impaired kidney function in the transplant recipients. We undertook a multicentre randomised study to assess the frequency of acute renal failure (ARF) in patients with severe sepsis or septic shock treated with hydroxyethylstarch or gelatin.
METHODS:
Adults with severe sepsis or septic shock were enrolled prospectively in three intensive-care units in France. They were randomly assigned 6% hydroxyethylstarch (200 kDa, 0.60-0.66 substitution) or 3% fluid-modified gelatin. The primary endpoint was ARF (a two-fold increase in serum creatinine from baseline or need for renal replacement therapy). Analyses were by intention to treat.
FINDINGS:
129 patients were enrolled over 18 months. Severity of illness and serum creatinine (median 143 [IQR 88-203] vs 114 [91-175] micromol/L) were similar at baseline in the hydroxyethylstarch and gelatin groups. The frequencies of ARF (27/65 [42%] vs 15/64 [23%], p=0.028) and oliguria (35/62 [56%] vs 23/63 [37%], p=0.025) and the peak serum creatinine concentration (225 [130-339] vs 169 [106-273] micromol/L, p=0.04) were significantly higher in the hydroxyethylstarch group than in the gelatin group. In a multivariate analysis, risk factors for acute renal failure included mechanical ventilation (odds ratio 4.02 [95% CI 1.37-11.8], p=0.013) and use of hydroxyethylstarch (2.57 [1.13-5.83], p=0.026).
INTERPRETATIONS:
The use of this preparation of hydroxyethylstarch as a plasma-volume expander is an independent risk factor for ARF in patients with severe sepsis or septic shock.
AuthorsF Schortgen, J C Lacherade, F Bruneel, I Cattaneo, F Hemery, F Lemaire, L Brochard
JournalLancet (London, England) (Lancet) Vol. 357 Issue 9260 Pg. 911-6 (Mar 24 2001) ISSN: 0140-6736 [Print] England
PMID11289347 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxyethyl Starch Derivatives
  • Plasma Substitutes
  • Gelatin
Topics
  • Acute Kidney Injury (chemically induced)
  • Adult
  • Aged
  • Female
  • Fluid Therapy (adverse effects, methods)
  • France (epidemiology)
  • Gelatin (adverse effects)
  • Humans
  • Hydroxyethyl Starch Derivatives (adverse effects)
  • Intensive Care Units
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Plasma Substitutes (adverse effects)
  • Prospective Studies
  • Risk
  • Sepsis (complications, mortality, therapy)
  • Shock, Septic (complications, mortality, therapy)
  • Statistics, Nonparametric
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: